| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0008 |